In8bio
IN8bio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Gamma-delta T cells are naturally occurring immune cells that embody properties of both the innate and adaptive immune systems,...
View Top Employees for In8bio
|
Website | in8bio.com |
|
Industry | Biotechnology |
|
Location | New York, United States |
|
Employees | 9 |
|
Founded | 2016 |
|
HQ | 79 Madison Avenue |
|
Funding | 34,980,581 USD |
|
|
Website | in8bio.com |
|
|
Industry | Biotechnology |
|
|
Location | New York, United States |
|
|
Employees | 9 |
|
|
Founded | 2016 |
|
linkedin.com/company/in8bio | |
|
|
HQ | 79 Madison Avenue |
|
|
Funding | 34,980,581 USD |
In8bio Questions
Where are In8bio's headquarters?
In8bio's headquarters are in 79 Madison Avenue
What is In8bio's official website?
In8bio's website is in8bio.com
How many employees are working in In8bio right now?
In8bio has
9 employees.
View the Email and Phone Numbers for all 9 working at In8bio.
What is In8bio's industry?
In8bio's industry is
Biotechnology
What are In8bio's categories?
In8bio's categories are Biotechnology, Health Care, Therapeutics
What is In8bio's location?
In8bio's location is
New York, United States
When was In8bio's founded?
In8bio's founding year is 2016
What is In8bio's funding?
In8bio's funding is 34,980,581 USD
What is In8bio's current status?
In8bio's current status is ipo
